Thuss-Patience, P; Arnold, D; Stein, A et al.
THE TEX REGIMEN (DOCETAXEL, OXALIPLATIN AND CAPECITABINE) IN PATIENTS WITH ADVANCED OR METASTATIC GASTRIC AND GASTROESOPHAGEAL CANCER: RESULTS FROM A PHASE II TRIAL OF THE GERMAN AIO GROUPANNALS OF ONCOLOGY. Bd. 21. 2010 S. 90-90
Dunschede, F; Will, L; von Langsdorf, C et al.
Treatment of Metachronous and Simultaneous Liver Metastases of Pancreatic CancerEUROPEAN SURGICAL RESEARCH. Bd. 44. H. 3-4. 2010 S. 209-213
Holtmann, MH; Barreiros, AP; Mudter, J et al.
Ultrasound Education by Simulator Training - Analysis of the Largest Simulator-Based Training in GermanyZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 48. H. 11. 2010 S. 1279-1284
Leffler, DA; Schuppan, D
Update on Serologic Testing in Celiac DiseaseAMERICAN JOURNAL OF GASTROENTEROLOGY. Bd. 105. H. 12. 2010 S. 2520-2524
Waldner, MJ; Wirtz, S; Jefremow, A et al.
VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancerJOURNAL OF EXPERIMENTAL MEDICINE. Bd. 207. H. 13. 2010 S. 2855-2868
Marker-Hermann, E; Schutz, N; Bauer, H
Viral arthritidesZEITSCHRIFT FUR RHEUMATOLOGIE. Bd. 69. H. 10. 2010 S. 871-878
Berg, T; Dieterich, DT; Lalezari, JP et al.
VIROLOGICAL RESPONSE AND SAFETY OF 4 WEEKS TREATMENT WITH THE PROTEASE INHIBITOR BI 201335 COMBINED WITH 48 WEEKS OF PEGINTERFERON ALFA 2A AND RIBAVIRIN FOR TREATMENT OF HCV GT-1 PATIENTS WHO FAILED PEGINTERFERON/RIBAVIRINHEPATOLOGY. Bd. 52. H. 4. 2010 S. 704A-705A
Sydor, S; Gu, YL; Sowa, JP et al.
WESTERN DIET ENHANCES EXPRESSION OF DEATH RECEPTORS AND FATTY ACID TRANSPORTERS IN A MOUSE MODEL OF 70% HEPATECTOMY AND LEADS TO INCREASED CELL PROLIFERATION IN THE LIVERHEPATOLOGY. Bd. 52. H. 4. 2010 S. 1056A-1056A
Braner, A; Krummel-Lorenz, B; Marker-Herrmann, E
3-year follow-up for anakinra-treatment in a patient with familial mediterranian fever following intolerance to colchicineEUROPEAN JOURNAL OF CLINICAL INVESTIGATION. Bd. 39. 2009 S. 11-11
Maxeiner, JH; Karwot, R; Sauer, K et al.
A Key Regulatory Role of the Transcription Factor NFATc2 in Bronchial Adenocarcinoma via CD8(+) T LymphocytesCANCER RESEARCH. Bd. 69. H. 7. 2009 S. 3069-3076